CAREFUSION CORP Forms 3, 4 and 5: Restricted Stock Units and Performance Rights
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 43 rows in 2012. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2012-12-12: Reporting owner Maschal Jean; Form 4; Security Restricted Stock Units; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2012-12-12: Reporting owner La Fortune Gordon; Form 4/A; Security Restricted Stock Units; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2012-11-02: Reporting owner WAYMAN ROBERT PAUL; Form 4; Security Restricted Stock Units; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2012-11-02: Reporting owner OHALLERAN MICHAEL D; Form 4; Security Restricted Stock Units; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2012-12-12 | Maschal Jean Officer (SVP, Chief Accounting Officer) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −89 2,541 owned after | no price filed | 2012-12-13 | |
| 2012-12-12 | La Fortune Gordon Officer (EVP, EMEA/APAC Commercial Ops) | 4/A | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −87 3,869 owned after | no price filed | 2012-12-13 | |
| 2012-11-02 | WAYMAN ROBERT PAUL Director | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,019 0 owned after | no price filed | 2012-11-06 | |
| 2012-11-02 | OHALLERAN MICHAEL D Director | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,019 0 owned after | no price filed | 2012-11-06 | |
| 2012-11-02 | MILLER EDWARD D JR Director | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,019 0 owned after | no price filed | 2012-11-06 | |
| 2012-11-02 | LUCIER GREGORY T Director | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,019 0 owned after | no price filed | 2012-11-06 | |
| 2012-11-02 | LOSH J MICHAEL Director | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,019 0 owned after | no price filed | 2012-11-06 | |
| 2012-11-02 | KOSECOFF JACQUELINE B Director | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,019 0 owned after | no price filed | 2012-11-06 | |
| 2012-11-02 | FRIEL ROBERT F Director | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,019 0 owned after | no price filed | 2012-11-06 | |
| 2012-11-02 | FRANCIS PHILIP L Director | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,019 0 owned after | no price filed | 2012-11-06 | |
| 2012-09-15 | Stafslien Joan Officer (EVP, General Counsel) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −17,102 0 owned after | no price filed | 2012-09-18 | |
| 2012-09-15 | Maschal Jean Officer (SVP, Chief Accounting Officer) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,993 0 owned after | no price filed | 2012-09-18 | |
| 2012-09-15 | Leonard Thomas J Officer (President, Medical Systems) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,895 0 owned after | no price filed | 2012-09-18 | |
| 2012-09-15 | La Fortune Gordon Officer (EVP, EMEA/APAC Commercial Ops) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,902 0 owned after | no price filed | 2012-09-18 | |
| 2012-09-15 | Jain Vivek Officer (Pres., Procedural Solutions) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,371 0 owned after | no price filed | 2012-09-18 | |
| 2012-09-15 | Hinrichs James F. Officer (Chief Financial Officer) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −18,280 0 owned after | no price filed | 2012-09-18 | |
| 2012-09-15 | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,328 0 owned after | no price filed | 2012-09-18 | |
| 2012-08-16 | Stafslien Joan Officer (EVP, General Counsel) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,880 3,880 owned after | no price filed | 2012-08-16 | |
| 2012-08-16 | Maschal Jean Officer (SVP, Chief Accounting Officer) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,415 1,519 owned after | no price filed | 2012-08-16 | |
| 2012-08-16 | Leonard Thomas J Officer (President, Medical Systems) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,621 3,622 owned after | no price filed | 2012-08-16 | |
| 2012-08-16 | La Fortune Gordon Officer (EVP, EMEA/APAC Commercial Ops) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,410 3,410 owned after | no price filed | 2012-08-16 | |
| 2012-08-16 | Jain Vivek Officer (Pres., Procedural Solutions) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,901 3,901 owned after | no price filed | 2012-08-16 | |
| 2012-08-16 | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,245 3,246 owned after | no price filed | 2012-08-16 | |
| 2012-08-16 | Hinrichs James F. Officer (Chief Financial Officer) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,237 5,237 owned after | no price filed | 2012-08-16 | |
| 2012-08-15 | Gallahue Kieran Director, Officer (Chairman and CEO) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −24,452 48,905 owned after | no price filed | 2012-08-16 | |
| 2012-08-15 | Gallahue Kieran Director, Officer (Chairman and CEO) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +69,989 69,989 owned after | no price filed | 2012-08-16 | |
| 2012-08-15 | Stafslien Joan Officer (EVP, General Counsel) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,362 6,725 owned after | no price filed | 2012-08-16 | |
| 2012-08-15 | Stafslien Joan Officer (EVP, General Counsel) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,105 10,105 owned after | no price filed | 2012-08-16 | |
| 2012-08-15 | Maschal Jean Officer (SVP, Chief Accounting Officer) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,314 2,360 owned after | no price filed | 2012-08-16 | |
| 2012-08-15 | Maschal Jean Officer (SVP, Chief Accounting Officer) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,914 3,914 owned after | no price filed | 2012-08-16 | |
| 2012-08-15 | MARCHETTI ROGER Officer (EVP, Human Resources) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,688 17,378 owned after | no price filed | 2012-08-16 | |
| 2012-08-15 | MARCHETTI ROGER Officer (EVP, Human Resources) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,305 7,305 owned after | no price filed | 2012-08-16 | |
| 2012-08-15 | Leonard Thomas J Officer (President, Medical Systems) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,720 7,442 owned after | no price filed | 2012-08-16 | |
| 2012-08-15 | Leonard Thomas J Officer (President, Medical Systems) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +13,547 13,547 owned after | no price filed | 2012-08-16 | |
| 2012-08-15 | La Fortune Gordon Officer (EVP, EMEA/APAC Commercial Ops) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,977 3,956 owned after | no price filed | 2012-08-16 | |
| 2012-08-15 | La Fortune Gordon Officer (EVP, EMEA/APAC Commercial Ops) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,719 6,719 owned after | no price filed | 2012-08-16 | |
| 2012-08-15 | Jain Vivek Officer (Pres., Procedural Solutions) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,903 7,808 owned after | no price filed | 2012-08-16 | |
| 2012-08-15 | Jain Vivek Officer (Pres., Procedural Solutions) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,291 12,291 owned after | no price filed | 2012-08-16 | |
| 2012-08-15 | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,491 2,984 owned after | no price filed | 2012-08-16 | |
| 2012-08-15 | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,524 5,524 owned after | no price filed | 2012-08-16 | |
| 2012-08-15 | Hinrichs James F. Officer (Chief Financial Officer) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,782 15,565 owned after | no price filed | 2012-08-16 | |
| 2012-08-15 | Hinrichs James F. Officer (Chief Financial Officer) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +22,944 22,944 owned after | no price filed | 2012-08-16 | |
| 2012-01-29 | Gallahue Kieran Director, Officer (Chairman and CEO) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −126,676 253,353 owned after | no price filed | 2012-01-31 |